Stopping the HIV Epidemic: The Time Is Now

StopHIVEpidemic_Webpg_banner_v2.jpg 

Click Here to Launch On-Demand Program

   

About the Program:

Program Overview:

While there has been significant progress in the prevention of new HIV infections, transmission of HIV continues. Clearly, more needs to be done to reduce the rate of new infections through such approaches as increased HIV testing, behavioral interventions and the use of pre-exposure prophylaxis (PrEP). However, many clinicians are not fully equipped to guide their patients through the complex issues associated with HIV prevention. This situation results in patients not receiving optimal preventative care as described in national guidelines and to an increased number of people becoming infected with HIV who might otherwise not be infected.

This educational program has been designed to address these challenges. This program will include case studies that allow participants to see how the issues discussed can be applied to real-life situations, and participants will be encouraged to ask questions and interact with the speakers to keep the programs lively and engaging. The aim of this program is to educate clinicians who work with various patient populations - especially high-risk patients - about the theoretical framework, latest findings and ongoing research in this field, and to review the professional guidelines in this area. In addition, this program will educate clinicians with strategies to provide improved prevention services to patients, which is expected to help reduce the number of new HIV infections. 

Back to Top   

Target Audience:

This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals involved in the treatment and management of patients with HIV infection.

Back to Top

Program Objectives:

Upon completion of the program, participants should be able to:

  • Describe risk factors that contribute to the continued spread of HIV, especially in high-risk populations; 
  • Review the need for strategies to reduce the risk of new infections with HIV in various populations;

  • Explain the rationale behind various behavioral and medical prevention strategies, including how research findings on these approaches can be applied to clinical practice;

  • Discuss ongoing research on the use of vaccines, pre-exposure prophylaxis, post-exposure prophylaxis, and other prevention strategies in various populations;

  • Discuss with patients methods to minimize the spread of HIV infection.

Release Date: August 15, 2012

Expiration Date: August 15, 2013

Estimated time to complete this Web Symposium: 2 hours

Media: Internet

Back to Top

Course Director:

Calvin J. Cohen, MD, MS
Research Director, CRI New England
Clinical Instructor, Harvard Medical School
Boston, Massachusetts

Robert M. Grant, MD, MPH
Betty Jean and Hiro Ogawa
Endowed Investigator,
Gladstone Institute of Virology and Immunology
Associate Professor of Medicine,
University of California, San Francisco
San Francisco, California

Back to Top 

Faculty:

John Bartlett, MD
Professor of Medicine,
Johns Hopkins School of Medicine
Baltimore, Maryland

 

Richard A. Elion, MD
Associate Professor of Clinical Medicine,
George Washington University Medical Center
Washington, DC

 

Ian Frank, MD
Professor of Medicine,
Director, Antiretroviral Clinical Research
University of Pennsylvania
Philadelphia, Pennsylvania

 

David Wohl, MD
Associate Professor of Medicine,
Division of Infectious Diseases, School of Medicine,
The University of North Carolina,
Chapel Hill, North Carolina
Co-Director of HIV Services for the North Carolina
Department of Corrections
Chapel Hill, North Carolina

 
   
Back to Top

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Postgraduate Institute for Medicine and ViralEd, Inc.. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.    

Back to Top

Credit Designation Statement:

The Postgraduate Institute for Medicine designates this enduring material for a maximum 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

Disclosure of Conflicts of Interest:

The Postgraduate Institute for Medicine requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by the Postgraduate Institute for Medicine for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Dr. John Bartlett:

  • Nothing to Disclose

Dr. Calvin Cohen:

  • Contracted Research: BMS; Janssen; Merck; Gilead
  • Consulting Fees: BMS; Janssen; Merck; Gilead; Tobira

Dr. Richard Elion:

  • Contracted Research: Gilead; Tibotec; BMS; BI
  • Consulting Fees: Gilead; BMS; Tibotec
  • Fees of Non-CME/CE Services: Gilead; Tibotec; Merck

Dr. Ian Frank:

  • Contracted Research: GlaxoSmithKline
  • Consulting Fees: Gilead

Dr. Robert Grant:

  • Contracted Research: Gilead 

Dr. David Wohl:

  • Contracted Research: GSK; Merck
  • Consulting Fees: Tibotec; Gilead

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM staff serve as clinical content reviewers and/or participate in planning CME/CE activities in a manner that may affect content:, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP, Jan Schultz, RN, MSN, CCMEP, and Patricia Staples, MSN, NP-C, CCRN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME/CE activity of any amount during the past 12 months.

Back to Top

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Postgraduate Institute for Medicine, ViralEd, Inc. and Gilead Sciences Medical Affairs do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Postgraduate Institute for Medicine, ViralEd, Inc. and Gilead Sciences Medical Affairs. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings 

Instructions for Participation and Credit 

There are no fees for participating and receiving credit for this activity. During the period, Date August 15, 2012 through August 15, 2013, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and evaluation form.

To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on the Submit Post-test at the bottom of the page. Your post-test will automatically be graded.

If you successfully complete the post-test (score of 70% or higher). your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you received a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.

You may complete the Post-test on-line at www.cmeuniversity.com

  • Click on "Find Post-Test/Evaluation by Course" on the navigation menu
  • Search by project ID: 8562
  • Upon successfully completing the Post-test and Evaluation form, your certificate will be made available immediately.

Disclaimer: 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. 

Back to Top

Commercial Support Acknowledgement: 

Supported by an unrestricted educational grant from Gilead Sciences Medical Affairs.  

PIM_small    VE logo 300px

Prepare to print

Share this page:

Get link code to this page     


Back to Top